Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
How PlexusDx Supports Metabolic Optimization Beyond Weight Loss PlexusDx serves all 50 states without requiring insurance, membership fees, or pre-existing obesity diagnosis
"I just feel like a regular person who didn't have a weight problem." Managing side effects Brandon Blakeley, CTO of Mirador Living, went on Ozempic in January 2022
According to NICE guideline NG28, GLP-1 receptor agonists should be considered when: Triple therapy (metformin and two other oral drugs) is not effective, not tolerated, or contraindicated The patient has a BMI 35 kg/m (or lower in people of Black, Asian and other minority ethnic groups) and specific obesity-related comorbidities The patient has a BMI 40% reduction in non-HDL cholesterol GLP-1 receptor agonist for glycaemic control and weight management (with secondary lipid benefits) Ezetimibe if non-HDL cholesterol reduction is insufficient Lifestyle interventions addressing diet, exercise, and weight Monitoring and follow-up are essential components of cholesterol management
Schmitt M, Ewendt F, Kluttig A, Mikolajczyk R, Kraus FB, Wtjen W, et al
In modern healthcare, vitamin deficiencies are more common than many people realize
US$ 22.08
US$ 27.26
US$ 21.89
US$ 27.59
US$ 21.62
US$ 25.38
US$ 28.15
US$ 29.92
US$ 28.35
US$ 23.02
US$ 20.95
US$ 26.59
US$ 23.88
US$ 21.81
US$ 27.44
US$ 29.69
